High expression of NPAS2 was correlated with poor survival in LUAD and liver cancer, and abnormal expression also contributed to T cell exhaustion and upregulation of immune checkpoint molecules and TNF signaling pathway 37, 38. The gene discussed is NPAS2; the disease is liver cancer.